Redox homeostasis, T cells and kidney diseases: Three faces in the dark

Clinical Kidney Journal

Volumn 9, Issue 1, 2016, Pages 1-10

  Simeoni, Luca ^a   Thurm, Christoph ^a   Kritikos, Andreas ^a   Linkermann, Andreas ^b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

acute kidney injury; autoimmunity; end stage kidney disease; systemic lupus erythematosus (SLE); T cell activation

Indexed keywords

GLUTATHIONE; LIPID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2;

ANTIGEN PRESENTING CELL; END STAGE RENAL DISEASE; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY ISCHEMIA; LIPID OXIDATION; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; OXIDATION REDUCTION STATE; PATHOGENESIS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 85007232629     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfv135     Document Type: Review

References (119)

1. Lei Y, Wang K, Deng L et al. Redox regulation of inflammation: Old elements, a newstory. Med Res Rev 2015; 35: 306-340
2. Dixon SJ, Lemberg KM, Lamprecht MR et al. Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell 2012; 149: 1060-1072
3. Linkermann A, Skouta R, Himmerkus N et al. Synchronized renal tubular cell death involves ferroptosis. Proc Natl Acad Sci USA 2014; 111: 16836-16841
4. Vanden Berghe T, Linkermann A, Jouan-Lanhouet S et al. Regulated necrosis: The expanding network of non-Apoptotic cell death pathways. Nat Rev Mol Cell Biol 2014; 15: 135-147
5. Smith-Garvin JE, Koretzky GA, Jordan MS. T cell activation. Annu Rev Immunol 2009; 27: 591-619
6. Lanzavecchia A, Sallusto F. Regulation of T cell immunity by dendritic cells. Cell 2001; 106: 263-266
7. Vega-Ramos J, Roquilly A, Asehnoune K et al. Modulation of dendritic cell antigen presentation by pathogens, tissue damage and secondary inflammatory signals. Curr Opin Pharmacol 2014; 17: 64-70
8. Macagno A, Napolitani G, Lanzavecchia A et al. Duration, combination and timing: The signal integration model of dendritic cell activation. Trends Immunol 2007; 28: 227-233
9. Raphael I, Nalawade S, Eagar TN et al. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine 2015; 74: 5-17
10. Schmitt N, Ueno H. Regulation of human helper T cell subset differentiation by cytokines. Curr Opin Immunol 2015; 34: 130-136
11. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82: 47-95
12. Valko M, Leibfritz D, Moncol J et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84
13. Yan Z, Banerjee R. Redox remodeling as an immunoregulatory strategy. Biochemistry 2010; 49: 1059-1066
14. Simeoni L, Bogeski I. Redox regulation of T-cell receptor signaling. Biol Chem 2015; 396: 555-568
15. Staal FJ, Anderson MT, Staal GE et al. Redox regulation of signal transduction: Tyrosine phosphorylation and calcium influx. Proc Natl Acad Sci USA 1994; 91: 3619-3622
16. Suthanthiran M, Anderson ME, Sharma VK et al. Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc Natl Acad Sci USA 1990; 87: 3343-3347
17. Kaminski MM, Sauer SW, Klemke CD et al. Mitochondrial reactive oxygen species control T cell activation by regulating IL-2 and IL-4 expression: Mechanism of ciprofloxacinmediated immunosuppression. J Immunol 2010; 184: 4827-4841
18. Sena LA, Li S, Jairaman A et al. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 2013; 38: 225-236
19. Li-Weber M, Giaisi M, TreiberMKet al. Vitamin E inhibits IL-4 gene expression in peripheral blood T cells. Eur J Immunol 2002; 32: 2401-2408
20. Roth S, Droge W. Regulation of T-cell activation and T-cell growth factor (TCGF) production by hydrogen peroxide. Cell Immunol 1987; 108: 417-424
21. Los M, Schenk H, Hexel K et al. IL-2 gene expression and NFkappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J 1995; 14: 3731-3740
22. Hehner SP, Breitkreutz R, Shubinsky G et al. Enhancement of T cell receptor signaling by a mild oxidative shift in the intracellular thiol pool. J Immunol 2000; 165: 4319-4328
23. King MR, Ismail AS, Davis LS et al. Oxidative stress promotes polarization of human T cell differentiation toward a T helper 2 phenotype. J Immunol 2006; 176: 2765-2772
24. Jeannin P, Delneste Y, Lecoanet-Henchoz S et al. Thiols decrease human interleukin (IL) 4 production and IL-4-induced immunoglobulin synthesis. J Exp Med 1995; 182: 1785-1792
25. Bengtsson A, Lundberg M, Avila-Carino J et al. Thiols decrease cytokine levels and down-regulate the expression of CD30 on human allergen-specific T helper (Th) 0 and Th2 cells. Clin Exp Immunol 2001; 123: 350-360
26. Hoffmann FW, Hashimoto AC, Shafer LA et al. Dietary selenium modulates activation and differentiation of CD4+ T cells in mice through a mechanism involving cellular free thiols. J Nutr 2010; 140: 1155-1161
27. Snelgrove RJ, Edwards L, Rae AJ et al. An absence of reactive oxygen species improves the resolution of lung influenza infection. Eur J Immunol 2006; 36: 1364-1373
28. Jackson SH, Devadas S, Kwon J et al. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol 2004; 5: 818-827
29. Shatynski KE, Chen H, Kwon J et al. Decreased STAT5 phosphorylation and GATA-3 expression in NOX2-deficient T cells: Role in T helper development. Eur J Immunol 2012; 42: 3202-3211
30. Akilov OE, Ustyugova IV, Zhi L et al. Enhanced susceptibility to Leishmania infection in resistant mice in the absence of immediate early response gene X-1. J Immunol 2009; 183: 7994-8003
31. Zhi L, Ustyugova IV, Chen X et al. Enhanced Th17 differentiation and aggravated arthritis in IEX-1-deficient mice by mitochondrial reactive oxygen species-mediated signaling. J Immunol 2012; 189: 1639-1647
32. Noval Rivas M, Burton OT, Wise P et al. Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy. Immunity 2015; 42: 512-523
33. Gagliani N, Vesely MC, Iseppon A et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 2015; 523: 221-225
34. Kamide Y, Utsugi M, Dobashi K et al. Intracellular glutathione redox status in human dendritic cells regulates IL-27 production and T-cell polarization. Allergy 2011; 66: 1183-1192
35. Murata Y, Amao M, Yoneda J et al. Intracellular thiol redox status ofmacrophages directs the Th1 skewing in thioredoxin transgenic mice during aging. Mol Immunol 2002; 38: 747-757
36. Dobashi K, Aihara M, Araki T et al. Regulation of LPS induced IL-12 production by IFN-gamma and IL-4 through intracellular glutathione status in human alveolar macrophages. Clin Exp Immunol 2001; 124: 290-296
37. Kuppner MC, Scharner A, Milani V et al. Ifosfamide impairs the allostimulatory capacity of human dendritic cells by intracellular glutathione depletion. Blood 2003; 102: 3668-3674
38. KimHJ, Barajas B, ChanRCet al. Glutathione depletioninhibits dendritic cell maturation and delayed-type hypersensitivity: Implications for systemic disease and immunosenescence. J Allergy Clin Immunol 2007; 119: 1225-1233
39. Utsugi M, Dobashi K, Ishizuka T et al. c-Jun N-terminal kinase negatively regulates lipopolysaccharide-induced IL-12 production in human macrophages: Role of mitogenactivated protein kinase in glutathione redox regulation of IL-12 production. J Immunol 2003; 171: 628-635
40. Utsugi M, Dobashi K, Koga Y et al. Glutathione redox regulates lipopolysaccharide-induced IL-12 production through p38 mitogen-Activated protein kinase activation in human monocytes: Role of glutathione redox in IFN-gamma priming of IL-12 production. J Leukoc Biol 2002; 71: 339-347
41. Yamada H, Arai T, Endo N et al. LPS-induced ROS generation and changes in glutathione level and their relation to the maturation of human monocyte-derived dendritic cells. Life Sci 2006; 78: 926-933
42. Perricone C, De Carolis C, Perricone R. Glutathione: A key player in autoimmunity. Autoimmun Rev 2009; 8: 697-701
43. Rostami R, Aghasi MR, Mohammadi A et al. Enhanced oxidative stress in Hashimoto's thyroiditis: Inter-relationships to biomarkers of thyroid function. Clin Biochem 2013; 46: 308-312
44. Mikuls TR, Gould KA, Bynote KK et al. Anticitrullinated protein antibody (ACPA) in rheumatoid arthritis: Influence of an interaction between HLA-DRB1 shared epitope and a deletion polymorphism in glutathione S-transferase in a cross-sectional study. Arthritis Res Ther 2010; 12: R213
45. Wang G,Wang J, Fan X et al. Protein adducts of malondialdehyde and 4-hydroxynonenal contribute to trichloroethenemediated autoimmunity via activating Th17 cells: Dose- and time-response studies in female MRL+/+ mice. Toxicology 2012; 292: 113-122
46. Allan ER, Tailor P, Balce DR et al. NADPH oxidase modifies patterns of MHC class II-restricted epitopic repertoires through redox control of antigen processing. J Immunol 2014; 192: 4989-5001
47. Rybicka JM, Balce DR, Chaudhuri S et al. Phagosomal proteolysis in dendritic cells is modulated by NADPH oxidase in a pH-independent manner. EMBO J 2012; 31: 932-944
48. Takahashi H, Bordy MD, Sharma V et al. Hyperthyroidism in patients with Down's syndrome. Clin Pediatr (Phila) 1979; 18: 273-275
49. Sareila O, Kelkka T, Pizzolla A et al. NOX2 complex-derived ROS as immune regulators. Antioxid Redox Signal 2011; 15: 2197-2208
50. Schappi MG, Jaquet V, Belli DC et al. Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase. Semin Immunopathol 2008; 30: 255-271
51. Hultqvist M, Olsson LM, Gelderman KA et al. The protective role of ROS in autoimmune disease. Trends Immunol 2009; 30: 201-208
52. Jendrysik MA, Vasilevsky S, Yi L et al. NADPH oxidase-2 derived ROS dictates murine DC cytokine-mediated cell fate decisions during CD4T helper-cell commitment. PLoS One 2011; 6: E28198
53. Efimova O, Szankasi P, Kelley TW. Ncf1 (p47phox) is essential for direct regulatory T cell mediated suppression of CD4+ effector T cells. PLoS One 2011; 6: E16013
54. Ross R. Atherosclerosis-An inflammatory disease. N Engl J Med 1999; 340: 115-126
55. Kahlenberg JM, Kaplan MJ. Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus. Annu Rev Med 2013; 64: 249-263
56. Perrin-Cocon L, Diaz O, Andre P et al. Modified lipoproteins provide lipids that modulate dendritic cell immune function. Biochimie 2013; 95: 103-108
57. Ryu H, Chung Y. Regulation of IL-17 in atherosclerosis and related autoimmunity. Cytokine 2015; 74: 219-227
58. Dieckmann M, Dietrich MF, Herz J. Lipoprotein receptors- an evolutionarily ancient multifunctional receptor family. Biol Chem 2010; 391: 1341-1363
59. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011; 12: 204-212
60. Mallat Z, Gojova A, Brun V et al. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 2003; 108: 1232-1237
61. Lim H, Kim YU, Sun H et al. Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo. Immunity 2014; 40: 153-165
62. Rothe T, Gruber F, Uderhardt S et al. 12/15-Lipoxygenasemediated enzymatic lipid oxidation regulates DC maturation and function. J Clin Invest 2015; 125: 1944-1954
63. Friedmann Angeli JP, Schneider M, Proneth B et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol 2014; 16: 1180-1191
64. Yang WS, SriRamaratnam R, Welsch ME et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 2014; 156: 317-331
65. Mulay SR, Linkermann A, Anders HJ. Necroinflammation in kidney disease. J Am Soc Nephrol 2015; doi: 10.1681/ASN.2015040405.
66. Matsushita M, Freigang S, Schneider C et al. T cell lipid peroxidation induces ferroptosis and prevents immunity to infection. J Exp Med 2015; 212: 555-568
67. Fernandez D, Bonilla E, Mirza N et al. Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2983-2988
68. Suwannaroj S, Lagoo A, Keisler D et al. Antioxidants suppress mortality in the female NZB × NZW F1 mouse model of systemic lupus erythematosus (SLE). Lupus 2001; 10: 258-265
69. Lai ZW, Hanczko R, Bonilla E et al. N-Acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2012; 64: 2937-2946
70. Strickland FM, Hewagama A, Wu A et al. Diet influences expression of autoimmune-Associated genes and disease severity by epigenetic mechanisms in a transgenic mouse model of lupus. Arthritis Rheum 2013; 65: 1872-1881
71. Jardin F, Delorme G, Hardy A et al. Reevaluation of hemodynamic consequences of positive pressure ventilation: Emphasis on cyclic right ventricular afterloading by mechanical lung inflation. Anesthesiology 1990; 72: 966-970
72. Tsai PY, Ka SM, Chang JM et al. Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation. Free Radic Biol Med 2011; 51: 744-754
73. Lee H, Kim H, Lee G et al. Curcumin attenuates lupus nephritis upon interaction with regulatory T cells in New Zealand Black/White mice. Br J Nutr 2013; 110: 69-76
74. Feng L, Ke N, Cheng F et al. The protective mechanism of ligustrazine against renal ischemia/reperfusion injury. J Surg Res 2011; 166: 298-305
75. Hosseini F, Naseri MK, Badavi M et al. Effect of beta carotene on lipid peroxidation and antioxidant status following renal ischemia/reperfusion injury in rat. Scand J Clin Lab Invest 2010; 70: 259-263
76. Kizilgun M, Poyrazoglu Y, Oztas Y et al. Beneficial effects of N-Acetylcysteine and ebselen on renal ischemia/reperfusion injury. Ren Fail 2011; 33: 512-517
77. Yamamoto S, Hagiwara S, Hidaka S et al. The antioxidant EPC-K1 attenuates renal ischemia-reperfusion injury in a rat model. Am J Nephrol 2011; 33: 485-490
78. Li YW, Zhang Y, Zhang L et al. Protective effect of tea polyphenols on renal ischemia/reperfusion injury via suppressing the activation of TLR4/NF-kappaB p65 signal pathway. Gene 2014; 542: 46-51
79. Rah DK, Han DW, Baek HS et al. Protection of rabbit kidney from ischemia/reperfusion injury by green tea polyphenol pretreatment. Arch Pharm Res 2007; 30: 1447-1454
80. Guo CH, Wang CL. Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients. Int J Med Sci 2013; 10: 79-89
81. Rashidi AA, Salehi M, Piroozmand A et al. Effects of zinc supplementation on serum zinc and C-reactive protein concentrations in hemodialysis patients. J Ren Nutr 2009; 19: 475-478
82. Kim SH, Lee EK, Chang JW et al. Effects of Ginkgo biloba on haemostatic factors and inflammation in chronic peritoneal dialysis patients. Phytother Res 2005; 19: 546-548
83. Hung CH, Chan SH, Chu PM et al. Quercetin is a potent antiatherosclerotic compound by activation of SIRT1 signaling under oxLDL stimulation. Mol Nutr Food Res 2015; 59: 1905-1917
84. Tsai KL, Chen LH, Chiou SH et al. Coenzyme Q10 suppresses oxLDL-induced endothelial oxidative injuries by the modulation of LOX-1-mediated ROS generation via the AMPK/PKC/NADPH oxidase signaling pathway. Mol Nutr Food Res 2011; 55 (Suppl 2): S227-S240
85. Ishikawa A, Kawarazaki H, Ando K et al. Renal preservation effect of ubiquinol, the reduced form of coenzyme Q10. Clin Exp Nephrol 2011; 15: 30-33
86. Lee WJ, Ou HC, Hsu WC et al. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells. J Vasc Surg 2010; 52: 1290-1300
87. Ou HC, Hsieh YL, Yang NC et al. Ginkgo biloba extract attenuates oxLDL-induced endothelial dysfunction via an AMPK-dependent mechanism. J Appl Physiol 2013; 114: 274-285 (1985)
88. Ou HC, Song TY, Yeh YC et al. EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling. J Appl Physiol 2010; 108: 1745-1756
89. Guo H, Chen Y, Liao L et al. Resveratrol protects HUVECs from oxidized-LDL induced oxidative damage by autophagy upregulation via the AMPK/SIRT1 pathway. Cardiovasc Drugs Ther 2013; 27: 189-198
90. Carrasco J, Anglada FJ, Campos JP et al. The protective role of coenzyme Q10 in renal injury associated with extracorporeal shockwave lithotripsy: A randomised, placebocontrolled clinical trial. BJU Int 2014; 113: 942-950
91. Hye Khan MA, Neckar J, Manthati V et al. Orally active epoxyeicosatrienoic acid analog attenuates kidney injury in hypertensive Dahl salt-sensitive rat. Hypertension 2013; 62: 905-913
92. Tian N, Rose RA, Jordan S et al. N-Acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension. J Hypertens 2006; 24: 2263-2270
93. Perl A. Oxidative stress in the pathology and treatment of systemic lupus erythematosus. Nat Rev Rheumatol 2013; 9: 674-686
94. Shah D, Mahajan N, Sah S et al. Oxidative stress and its biomarkers in systemic lupus erythematosus. J Biomed Sci 2014; 21: 23
95. Strickland FM, Li Y, Johnson K et al. CD4(+) T cells epigenetically modified by oxidative stress cause lupus-like autoimmunity in mice. J Autoimmun 2015; 62: 75-80
96. Gorelik G, Sawalha AH, Patel D et al. T cell PKCdelta kinase inactivation induces lupus-like autoimmunity in mice. Clin Immunol 2015; 158: 193-203
97. Gorelik GJ, Yarlagadda S, Patel DR et al. Protein kinase Cdelta oxidation contributes to ERK inactivation in lupus T cells. Arthritis Rheum 2012; 64: 2964-2974
98. Desai-Mehta A, Lu L, Ramsey-Goldman R et al. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 1996; 97: 2063-2073
99. Gergely P Jr, Grossman C, Niland B et al. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum 2002; 46: 175-190
100. Lai ZW, Borsuk R, Shadakshari A et al. Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus. J Immunol 2013; 191: 2236-2246
101. Costenbader KH, Kang JH, Karlson EW. Antioxidant intake and risks of rheumatoid arthritis and systemic lupus erythematosus in women. Am J Epidemiol 2010; 172: 205-216
102. Huang L, Belousova T, Pan JS et al. AKI after conditional and kidney-specific knockdown of stanniocalcin-1. J Am Soc Nephrol 2014; 25: 2303-2315
103. Huang L, Belousova T, Chen M et al. Overexpression of stanniocalcin-1 inhibits reactive oxygen species and renal ischemia3reperfusion injury in mice. Kidney Int 2012; 82: 867-877
104. Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 1984; 74: 1156-1164
105. Karamouzis I, Sarafidis PA, KaramouzisMet al. Increase inoxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease. AmJNephrol 2008; 28: 397-404
106. Guo CH, Chen PC, Yeh MS et al. Cu/Zn ratios are associated with nutritional status, oxidative stress, inflammation, and immune abnormalities in patients on peritoneal dialysis. Clin Biochem 2011; 44: 275-280
107. Meier P, Golshayan D, Blanc E et al. Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD. J Am Soc Nephrol 2009; 20: 1368-1384
108. Gradinaru D, Borsa C, Ionescu C et al. Oxidized LDL and NO synthesis-biomarkers of endothelial dysfunction and ageing. Mech Ageing Dev 2015; 151: 101-113
109. Mattson DL. Infiltrating immune cells in the kidney in saltsensitive hypertension and renal injury. Am J Physiol Renal Physiol 2014; 307: F499-F508
110. De Miguel C, Guo C, Lund H et al. Infiltrating T lymphocytes in the kidney increase oxidative stress and participate in the development of hypertension and renal disease. AmJ Physiol Renal Physiol 2011; 300: F734-F742
111. Adema GJ. Dendritic cells from bench to bedside and back. Immunol Lett 2009; 122: 128-130
112. Delamarre L, Mellman I. Harnessing dendritic cells for immunotherapy. Semin Immunol 2011; 23: 2-11
113. Cosmi L, Maggi L, Santarlasci V et al. T helper cells plasticity in inflammation. Cytometry A 2014; 85: 36-42
114. Poole LB. Measurement of protein sulfenic acid content. Curr Protoc Toxicol 2008; Chapter 17: Unit 17.2
115. Lindemann C, Leichert LI. Quantitative redox proteomics: The NOxICAT method. Methods Mol Biol 2012; 893: 387-403
116. Ckless K. Redox proteomics: From bench to bedside. Adv Exp Med Biol 2014; 806: 301-317
117. Seo YH, Carroll KS. Profiling protein thiol oxidation in tumor cells using sulfenic acid-specific antibodies. Proc Natl Acad Sci USA 2009; 106: 16163-16168
118. Kettenhofen NJ, Wood MJ. Formation, reactivity, and detection of protein sulfenic acids. Chem Res Toxicol 2010; 23: 1633-1646
119. Leonard SE, Reddie KG, Carroll KS. Mining the thiol proteome for sulfenic acid modifications reveals new targets for oxidation in cells. ACS Chem Biol 2009; 4: 783-799